ALTOS Biologics, a subsidary of Alteogen, specializes in the development and marketing of biosimilars.
Developer of human hyaluronidase technology designed to facilitate global technology transfer. It is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out discussions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.